Impact of COVID-19 lockdown on routine oncology versus emergency care at a high volume cancer centre.
Christoph MinichsdorferGeorg JeryczynskiChristoph KrallAlina Magdalena AchhornerAriane CaraanSabina PasalicKatharina ReiningerChristina WagnerRupert BartschMatthias PreusserAnton LaggnerMarkus RadererThorsten FuerederPublished in: European journal of clinical investigation (2021)
We demonstrate the feasibility of maintaining antineoplastic therapy administration during the COVID-19 pandemic. However, our data underline the need for adapted management strategies for emergency presentations of cancer patients.
Keyphrases
- healthcare
- palliative care
- public health
- emergency department
- coronavirus disease
- papillary thyroid
- sars cov
- squamous cell
- electronic health record
- quality improvement
- clinical practice
- emergency medical
- stem cells
- lymph node metastasis
- squamous cell carcinoma
- pain management
- childhood cancer
- machine learning
- bone marrow
- affordable care act
- data analysis
- mesenchymal stem cells
- smoking cessation